KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Esperion Therapeutics (ESPR) Inventory Average (2020 - 2026)

Esperion Therapeutics filings provide 6 years of Inventory Average readings, the most recent being $106.8 million for Q4 2025.

  • On a quarterly basis, Inventory Average rose 22.38% to $106.8 million in Q4 2025 year-over-year; TTM through Dec 2025 was $106.8 million, a 22.38% increase, with the full-year FY2025 number at $99.8 million, up 24.67% from a year prior.
  • Inventory Average hit $106.8 million in Q4 2025 for Esperion Therapeutics, down from $111.5 million in the prior quarter.
  • In the past five years, Inventory Average ranged from a high of $111.5 million in Q3 2025 to a low of $18.1 million in Q1 2021.
  • Median Inventory Average over the past 5 years was $45.5 million (2023), compared with a mean of $57.9 million.
  • Biggest five-year swings in Inventory Average: soared 333.58% in 2021 and later fell 5.3% in 2022.
  • Esperion Therapeutics' Inventory Average stood at $34.2 million in 2021, then fell by 5.3% to $32.4 million in 2022, then soared by 80.8% to $58.5 million in 2023, then skyrocketed by 49.15% to $87.3 million in 2024, then grew by 22.38% to $106.8 million in 2025.
  • The last three reported values for Inventory Average were $106.8 million (Q4 2025), $111.5 million (Q3 2025), and $106.9 million (Q2 2025) per Business Quant data.